Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics

References

• Abdullahi, M., Shallangwa, G. A., Ibrahim, M. T., Bello, A. U., Arthur, D. E., Uzairu, A., & Mamza, P. (2018). QSAR Studies on some C14-urea tetrandrine compounds as potent anti-cancer agents against leukemia cell line (K562). Journal of Turkish Chemical Society, 5(3), 1387–1398.
   Google Scholar
• An, H.-X., Beckmann, M. W., Reifenberger, G., Bender, H. G., & Niederacher, D. (1999). Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. The American Journal of Pathology, 154(1), 113–118. https://doi.org/10.1016/S0002-9440(10)65257-1
   PubMed Web of Science ®Google Scholar
• Balasubramanian, P. K., Lee, Y., & Kim, Y. (2019). Identification of ligand-binding hotspot residues of CDK4 using molecular docking and molecular dynamics simulation. Bulletin of the Korean Chemical Society, 40(10), 1025–1032. https://doi.org/10.1002/bkcs.11873
   Web of Science ®Google Scholar
• Chen, P., Lee, N. V., Hu, W., Xu, M., Ferre, R. A., Lam, H., Bergqvist, S., Solowiej, J., Diehl, W., He, Y.-A., Yu, X., Nagata, A., VanArsdale, T., & Murray, B. W. (2016). Spectrum and degree of CDK drug interactions predicts clinical performance. Molecular Cancer Therapeutics, 15(10), 2273–2281. https://doi.org/10.1158/1535-7163.MCT-16-0300
   PubMed Web of Science ®Google Scholar
• Chirico, N., & Gramatica, P. (2011). Real external predictivity of QSAR models: How to evaluate it? comparison of different validation criteria and proposal of using the concordance correlation coefficient. Journal of Chemical Information and Modeling, 51(9), 2320–2335. https://doi.org/10.1021/ci200211n
   PubMed Web of Science ®Google Scholar
• Cho, Y. S., Angove, H., Brain, C., Chen, C. H.-T., Cheng, H., Cheng, R., Chopra, R., Chung, K., Congreve, M., Dagostin, C., Davis, D. J., Feltell, R., Giraldes, J., Hiscock, S. D., Kim, S., Kovats, S., Lagu, B., Lewry, K., Loo, A., … Howard, S. (2012). Fragment-based discovery of 7-azabenzimidazoles as potent, highly selective, and orally active CDK4/6 inhibitors. ACS Medicinal Chemistry Letters, 3(6), 445–449. https://doi.org/10.1021/ml200241a
   PubMed Web of Science ®Google Scholar
• Cho, Y. S., Borland, M., Brain, C., Chen, C. H.-T., Cheng, H., Chopra, R., Chung, K., Groarke, J., He, G., Hou, Y., Kim, S., Kovats, S., Lu, Y., O’Reilly, M., Shen, J., Smith, T., Trakshel, G., Vögtle, M., Xu, M., Xu, M., & Sung, M. J. (2010). 4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6. Journal of Medicinal Chemistry, 53(22), 7938–7957. https://doi.org/10.1021/jm060522a https://doi.org/10.1021/jm100571n
   PubMed Web of Science ®Google Scholar
• Chukwuemeka, P. O., Olowosoke, C. B., & Oretade, O. M. (2020). SARS-CoV-2 recombinant spike protein-based vaccine: A promising candidate against the recent imperial coronavirus disease (COVID-19). International Journal of Pathogen Research, 4(3), 40–62. https://doi.org/10.9734/ijpr/2020/v4i330115
   Google Scholar
• Consonni, V., Ballabio, D., & Todeschini, R. (2010). Evaluation of model predictive ability by external validation techniques. Journal of Chemometrics, 24(3–4), 194–201. https://doi.org/10.1002/cem.1290
   Web of Science ®Google Scholar
• Golbraikh, A., & Tropsha, A. (2002). Beware of q2!. Journal of Molecular Graphics & Modelling, 20(4), 269–276. https://doi.org/10.1016/s1093-3263(01)00123-1
   PubMed Web of Science ®Google Scholar
• Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advance semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 17. https://doi.org/10.1186/1758-2946-4-17
   PubMed Web of Science ®Google Scholar
• Jie, Z., Lina, X., Haichuan, Z., Ji, C., Xiaoyun, F., Sha, L., Fen, J., Yuming, L., & Baoquan, C. (2014). Synthesis and antitumor Activities of 1,3,4-thiadiazole derivatives possessing benzisoselenazolone Scaffold. Chemical Research in Chinese Universities, 30(5), 764–769. https://doi.org/10.1007/s40242-014-4080-4
   Web of Science ®Google Scholar
• Kennard, R. W., & Stone, L. A. (1969). Computer aided drug design of experiments. Technometrics, 11(1), 137–148. https://doi.org/10.1080/00401706.1969.10490666
   Web of Science ®Google Scholar
• Klamt, A., & Schuurmann, G. (1993). COSMO: A new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. Journal of the Chemical Society, Perkin Transactions, 2(5), 799–805. https://doi.org/10.1039/P29930000799
   Google Scholar
• Li, S., Wang, H.-X., Liu, H.-Y., Jing, F., Fu, X.-Y., Li, C.-W., Shi, Y.-P., & Chen, B.-Q. (2019). Synthesis and biological evaluation of novel disulfides incorporating 1,3,4-thiadiazole scaffold as promising antitumor agents. Medicinal Chemistry Research, 28(9), 1502–1508. https://doi.org/10.1007/s00044-019-02389-3
   Web of Science ®Google Scholar
• Luo, Z., Chen, B., He, S., Shi, Y., Liu, Y., & Li, C. (2012). Synthesis and antitumor-evaluation of 1,3,4-thiadiazole-containing benzisoselenazolone derivatives. Bioorganic & Medicinal Chemistry Letters, 22(9), 3191–3193. https://doi.org/10.1016/j.bmcl.2012.03.043
   PubMed Web of Science ®Google Scholar
• Luo, X., Zhao, Y., Tang, P., Du, X., Li, F., Wang, Q., Li, R., & He, J. (2021). Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches. Molecular Diversity, 25(1), 367–382. https://doi.org/10.1007/s11030-020-10120-3
   PubMed Web of Science ®Google Scholar
• Malumbres, M., & Barbacid, M. (2009). Cell cycle, CDKs and cancer: A changing paradigm. Nature Reviews. Cancer, 9(3), 153–166. https://doi.org/10.1038/nrc2602
   PubMed Web of Science ®Google Scholar
• Masand, V. H., Mahajan, D. T., Gramatica, P., & Barlow, J. (2014). Tasutomerism and multiple modelling enhance QSAR: Antimalaria activity of phosphoramidate and phosphorothioamidate analogues of amiprophos methyl. Medicinal Chemistry Research, 23(11), 4825–4835. https://doi.org/10.1007/s00044-014-1043-8
   Web of Science ®Google Scholar
• Masand, V. H., Mahajan, D. T., Nazeruddin, G. M., Hadda, B. T., Rastija, V., & Alfeefy, A. M. (2015). Effect of information leakage and method of splitting (rational and random) on external predicitve ability and behaviour of different statistical parameters of QSAR model. Medicinal Chemistry Research, 24(3), 1241–1264. https://doi.org/10.1007/s00044-014-1193-8
   Web of Science ®Google Scholar
• Mathew, V., Keshavayya, J., Vaidya, V. P., & Giles, D. (2007). Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4,b]-1,3,4-thiadiazoles and their dihydro analogues. European Journal of Medicinal Chemistry, 42(6), 823–840. https://doi.org/10.1016/j.ejmech.2006.12.010
   PubMed Web of Science ®Google Scholar
• Mayer, E. (2015). Targeting breast cancer with CDK inhibitors. Current Oncology Reports, 17(5), 443. https://doi.org/10.1007/s11912-015-0443-3
   PubMed Web of Science ®Google Scholar
• Padmavathi, V., Sudhaka, R. G., Padmaja, A., Kondaiah, P. & Ali-Shazia, (2009). Synthesis, antimicrobial and cytotoxic activities of 1,3,4, 1,3,4-thiadiazole and 1,2,4-triazoles. European Journal of Medicinal Chemistry, 44, 2106–2112.
   PubMed Web of Science ®Google Scholar
• Priya, D., & Kathiravan, M. K. (2020). Molecular insights into benzene sulphonamide substituted diarylpyrazoles as cyclooxygenase-2 inhibitor and its structural modification. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/10.1080/07391102.2020.1785329
   Google Scholar
• Revelant, G., Gadais, C., Mathieu, V., Kirsch, G., & Hesse, S. (2014). Synthesis and antiproliferative studies of 5-aryl-2-(3-thienylamino)-1,3,4-thiadiazole derivatives. Bioorganic & Medicinal Chemistry Letters, 24(12), 2724–2727. https://doi.org/10.1016/j.bmcl.2014.04.043
   PubMed Web of Science ®Google Scholar
• Roy, P. P., Kovarich, S., & Gramatica, P. (2011). QSAR model reproducibility and applicability: A case study of rate constants of hydroxyl radical reaction models applied to polybrominated diphenyl ethers and (benzo-)triazoles. Journal of Computational Chemistry, 32(11), 2386–2396. https://doi.org/10.1002/jcc.21820
   PubMed Web of Science ®Google Scholar
• Schüürmann, G., Ebert, R.-U., Chen, J., Wang, B., & Kühne, R. (2008). External validation and prediction employing the predictive squared correlation coefficient-test set activity mean vs training set activity mean. Journal of Chemical Information and Modeling, 48(11), 2140–2145. https://doi.org/10.1021/ci800253u
   PubMed Web of Science ®Google Scholar
• Shi, L. M., Fang, H., Tong, W., Wu, J., Perkins, R., Blair, R. M., Branham, W. S., Dial, S. L., Moland, C. L., & Sheehan, D. M. (2001). QSAR modelling using large diverse set of estrogens. Journal of Chemical Information and Computer Sciences, 41(1), 186–195. https://doi.org/10.1021/ci000066d
   PubMedGoogle Scholar
• Stewart, J. J. P. (1989). Optimization of parameters for semi-empirical methods I-method. Journal of Computational Chemistry, 107, 3902–3909.
   Google Scholar
• Stillings, M. R., Welbourn, A. P., & Walter, D. S. (1986). Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 2. Aminoalkyl derivatives. Journal of Medicinal Chemistry, 29(11), 2280–2284. https://doi.org/10.1021/jm00161a025
   PubMed Web of Science ®Google Scholar
• Timmermann, S., Hinds, P. W., & Munger, K. (1997). Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth and Differentiation-Publication American Association for Cancer Research, 8(4), 361–370.
   Google Scholar
• Tropsha, A. (2010). Best practices for QSAR model development, validation, and exploitation. Molecular Informatics, 29(6–7), 476–488. https://doi.org/10.1002/minf.201000061
   PubMed Web of Science ®Google Scholar
• Tropsha, A., Gramatica, P., & Gombar, V. K. (2003). The importance of being earnest: Validation is the absolute essential for successful application and interpretation of QSPR models. Molecular Informatics, 22, 69–77.
   Google Scholar
• Veerasamy, R., Rajak, H., Sivadasan, S., Varghes, C. P., & Agrawal, R. K. (2011). Validation of QSAR models-strategies and importance. International Journal of Drug Design and Discovery, 3, 511–519.
   Google Scholar
• Wang, X., Deng, K., Wang, C., Li, Y., Wang, T., Huang, Z., Ma, Y., Sun, P., Shi, Y., Yang, S., Fan, Y., & Xiang, R. (2020). Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 414–423. https://doi.org/10.1080/14756366.2019.1705290
   PubMed Web of Science ®Google Scholar
• Wu, Y., Zhang, Y., Pi, H., & Sheng, Y. (2020). Current therapeutic progress of CDK4/6 inhibitors in breast cancer. Cancer Management and Research, 12, 3477–3487. https://doi.org/10.2147/CMAR.S250632
   PubMed Web of Science ®Google Scholar
• Yap, C. W. (2011). PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. Journal of Computational Chemistry, 32(7), 1466–1474. https://doi.org/10.1002/jcc.21707
   PubMed Web of Science ®Google Scholar
• Yusuf, M., Khan, R., & Ahmed, B. (2008). Synthesis and anti-depressant activity of 5-amino-1, 3, 4-thiadiazole-2-thiol imines and thibenzyl derivatives. Bioorganic & Medicinal Chemistry, 16(17), 8029–8034. https://doi.org/10.1016/j.bmc.2008.07.056
   PubMed Web of Science ®Google Scholar
• Zhang, K., Wang, P., Xuan, L.-N., Fu, X.-Y., Jing, F., Li, S., Liu, Y.-M., & Chen, B.-Q. (2014). Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety. Bioorganic & Medicinal Chemistry Letters, 24(22), 5154–5156. https://doi.org/10.1016/j.bmcl.2014.09.086
   PubMed Web of Science ®Google Scholar